2017
DOI: 10.3892/mmr.2017.6119
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis for choroideremia in a large Chinese pedigree by next-generation sequencing (NGS) and non-invasive prenatal testing (NIPT)

Abstract: To develop an effective strategy to isolate and use cell-free fetal DNA (cffDNA) for the combined use of next-generation sequencing (NGS) for diagnosing choroideremia and non-invasive prenatal testing (NIPT) for Y chromosome determination, a large Chinese family with an X-linked recessive disease, choroideremia, was recruited. Cell-free DNA was extracted from maternal plasma, and SRY polymerase chain reaction amplification was performed using NIPT. Sanger sequencing was subsequently used for fetal amniotic flu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
27
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 21 publications
(27 citation statements)
references
References 41 publications
(61 reference statements)
0
27
0
Order By: Relevance
“…Here, we used capture agilent probes that were used in previously published studies [21,[26][27][28].…”
Section: Capture Panel Designingmentioning
confidence: 99%
“…Here, we used capture agilent probes that were used in previously published studies [21,[26][27][28].…”
Section: Capture Panel Designingmentioning
confidence: 99%
“…Here, we applied targeted next‐generation sequencing (TGS) technology, the most available ‎and promising method available, to identify a novel, homologous mutation of CDHR1 gene in a Chinese family with autosomal recessive retinal dystrophy, extending the gene's mutation spectrum.…”
Section: Introductionmentioning
confidence: 99%
“…The capture Agilent probes were used as in previously published studies [11,12,14,22] with a retinal disease capture panel that included FEVR-related genes: NDP, FZD4, LRP5, TSPAN12, ZNF408, CTNNB1, RCBTB1, and KIF11. In brief, 2 ÎŒg of the extracted proband gDNA was randomly sheared by sonication into 300-500 bp fragments.…”
Section: Capture Panel Design and Target Sequencingmentioning
confidence: 99%
“…To identify the disease-causing gene and to identify mutation, TES analyses were performed on the gDNA sample of the proband from pedigree M362 DNA, according to the instructions for Illumina pairedend libraries (Illumina, Inc., San Diego, CA) as reported previously [11,12,14]. The capture Agilent probes were used as in previously published studies [11,12,14,22] with a retinal disease capture panel that included FEVR-related genes: NDP, FZD4, LRP5, TSPAN12, ZNF408, CTNNB1, RCBTB1, and KIF11.…”
Section: Capture Panel Design and Target Sequencingmentioning
confidence: 99%
See 1 more Smart Citation